According to the Complaint, 22nd Century Group, Inc. ("22nd Century" or the "Company") provides technology that increases or decreases the nicotine levels and other nicotinic alkaloids in tobacco plants, and cannabinoids in
hemp/cannabis plants through genetic engineering and plant breeding.

According to the Complaint, Maxar is a leading global provider of advanced space technology solutions for commercial and government markets including satellites, Earth imagery, geospatial data and analytics, is at the nexus of the new space economy, developing and sustaining its infrastructure and delivering the products, services, systems and solutions that make it possible.

According to the Complaint, as of September 2017, Sogou was China's fourth largest Internet company based on MAU. By mobile queries, the Company's Sogou Search engine is the second largest search engine in China.

Plaintiff's law firm issued a press release on January 7, 2019, announcing the filing of the lawsuit. According to the press release, Liberty Health Sciences Inc. ("Liberty" or the "Company") was incorporated under the Business Corporations Act (British Columbia) on November 9, 2011, as SecureCom Mobile Inc. The Company's principal business activity is the production and distribution of medical cannabis through its wholly-owned subsidiary DFMMJ LLC (d/b/a Liberty Health Sciences Florida Ltd.). Aphria Inc., which also produces and distributes cannabis, has had long-standing ties with Liberty, starting from the very beginning of both companies.

Plaintiff's law firm issued a press release on January 3, 2019 announcing the filing of the Complaint. According to the press release, the Complaint alleges that on December 21, 2018, Perrigo issued a Form 8-K disclosing that the Company had received an audit finding letter from the Irish tax authorities on October 30, 2018 asserting "that IP sales transactions… including the sale of Tysabri®, were not part of the trade of Elan Pharma and therefore should have been treated as chargeable gains subject to an effective 33% tax rate, rather than the 12.5% tax rate applicable to trading income."

According to the Complaint, YRC Worldwide Inc. provides various transportation services primarily in North America. It operates as a holding company with two reporting segments: YRC Freight (longer haul trucking) and Regional Transportation (regional and next-day delivery markets).

According to the Complaint, Nova Lifestyle purports to design, manufacture, and sell residential and commercial furniture to middle and upper middle-income consumers worldwide.

According to the Complaint, Immunomedics purports to be a clinical-stage biopharmaceutical company developing monoclonal antibody-based products for the targeted treatment of cancer.

Plaintiff's law firm issued a press release on December 21, 2018, announcing the filing of the lawsuit. According to the press release, on July 16, 2018, JA Solar, purported to be one of the world's largest manufacturers of high-performance solar power products, completed its merger (the "Merger") with JASO Top Holdings Limited ("JASO Top"), JASO Holdings Limited ("Holdco"), JASO Parent Limited ("Parent"), and JASO Acquisition Limited ("Merger Sub") pursuant to the agreement and plan of merger dated November 17, 2017 by and among the parties. As a result of the Merger, the Company ceased to be a publicly traded company on the NASDAQ stock exchange.

According to the Complaint, Tenaris produces and sells seamless and welded steel tubular products and related services for the oil and gas industry, and other industrial applications.

On December 10, 2018, Plaintiff’s law firm issued a press release announcing the lawsuit. According to the press release, the Complaint alleges that during the Class Period, Defendants made false and misleading statements and/or failed to disclose adverse information regarding Nissan’s business and financial condition. Specifically, according to the Complaint, Nissan has been materially understating its expenses and overstating profits by concealing half of the annual executive compensation it was obligated to pay its former Chief Executive Officer (“CEO”) and Chairman of its Board of Directors (“Board”), in order to avoid shareholder scrutiny of the CEO’s inordinately high executive compensation. The Company also concealed from investors the significant defects in its corporate governance and internal controls and affirmatively failed to heed the express direction of its outside auditors dating back to at least 2013 to accurately report its executive compensation. Not only did the underreporting deceive Nissan’s investors, it violated the pay cap Nissan shareholders approved.

According to the Complaint, CURO Group Holdings Corp. ("CURO" or the Company) provides short-term credit to underbanked consumers in the United States, the United Kingdom and Canada. In the United States, it operates under two principal brands, "Speedy Cash" and "Rapid Cash." In the United Kingdom, CURO operates online as "Wage Day Advance" and "Juo Loans." In Canada, the Company's stores are branded "Cash Money" and it offers "LendDirect" installment loans online and at certain stores.

According to the Complaint, GreenSky, Inc. ("GreenSky" or the Company) is a financial technology company in Atlanta, Georgia. GreenSky operates an online platform that enables creditors to process loan applications at the point of sale. More than 10,000 businesses are active users of GreenSky's platform. Consumers who seek to make a purchase from such a business can apply for on-the-spot financing via the GreenSky mobile app.

According to the Complaint, PPDAI Group Inc. is an online P2P consumer finance company in China and the first online consumer finance marketplace in China connecting borrowers and investors whose needs are unserved or underserved by traditional financial institutions.

According to the Complaint, Ribbon, formerly Sonus, provided networked solutions from communications service providers and enterprises, bringing intelligence and security to real-time communications.

According to the Complaint, Evoqua purports to be a leading provider of mission critical water treatment solutions,
offering services, systems and technologies to support our customers' full water lifecycle needs. With over 200,000 installations worldwide, the Company holds leading positions in the industrial, commercial and municipal water treatment markets in North America. Evoqua offers a portfolio of differentiated, proprietary technology solutions sold under a number of brands. Evoqua claims that the customer intimacy created through its service network is a significant competitive advantage.

According to the Complaint, Ryanair is an airline operator based in Dublin, Ireland.

According to the Complaint, Align is a medical device company that purports to design, manufacture, and market products for the treatment of malocclusion or the misalignment of teeth. Invisalign is the proprietary name for the Company's clear aligners.

According to the Complaint, India Globalization Capital, Inc. (“IGC” or the Company) operates two distinct business segments. One segment develops and commercializes cannabinoid based alternative therapies for indications such as Alzheimer’sdisease, Parkinson’s disease, and pain. The Company’s second segment, operated since its inception, is a legacy business that involves trading commodities and heavy equipment rental.

On November 2, 2018, Plaintiff's law firm issued a press release announcing the lawsuit. According to the press release, Synchrony is a consumer financial services company. The Complaint alleges that during the Class Period, Synchrony falsely represented that its consistent and disciplined underwriting practices had led to a higher quality loan portfolio than those of its competitors. In truth, Synchrony relaxed its underwriting standards and increasingly offered private-label credit cards to riskier borrowers to sustain growth. The truth about Synchrony's credit standards began to be revealed on April 28, 2017, when the Company announced disappointing first quarter 2017 earnings driven by poor loan performance. This news caused Synchrony's shares to decline by $5.25 per share, or nearly 16%.